BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma
Figure 5
Measurement of levels of BMI-1 autoantibodies in normal, nasal polyp and cervical carcinoma sera.
Plots of levels of autoantibodies from the sera of 65 healthy donors and 67 cervical carcinoma patients measured through Elisa. Mean is shown by the horizontal bar inside the box and the two horizontal bars above and below the box represent ±2SD. The observations that fall outside 2SD from the mean are also shown in each plot. Values are expressed as absorbance.